Dr. Staci Gruber is the Director, Cognitive and Clinical Neuroimaging Core, McLean Hospital; the Director, Marijuana Investigations for Neuroscientific Discovery (MIND) Program, McLean Hospital; and an Associate Professor of Psychiatry, Harvard Medical School.
This video is her presentation to the Innovations in the Science of Cannabis Conference, May 17, 2021, McMaster University.
Dr. Staci Gruber, Director of the Cognitive and Clinical Neuroimaging Core at McLean Hospital and Associate Professor at Harvard Medical School, delves into the fascinating world of cannabis research.
With over three decades of expertise, Dr. Gruber explores the distinctions between recreational and medical cannabis use, highlighting their impacts on cognition, brain structure, and mental health. She shares groundbreaking findings from her longitudinal studies, including improvements in mood, anxiety, sleep, and cognitive performance among medical cannabis patients.
Dr. Gruber also discusses the potential risks and benefits of cannabis use across different age groups, emphasizing the importance of evidence-based research to guide policy and practice. Whether you’re a healthcare professional, researcher, or simply curious about cannabis, this talk offers invaluable insights into its therapeutic potential and societal implications.
0:00 Introduction
2:01 Financial Disclosures
2:29 Learning Objectives
3:29 Cannabis Cameos: HIGHlights
8:27 Cannabis & Cognition: Recent Research Findings
13:53 Neurobiologic Impact of RECREATIONAL CANNABIS USE
18:17 Cannabis & Older Adults: Preclinical Evidence
19:48 Medical # Recreational Cannabis Use
24:49 Longitudinal Study Overview
29:50 MC Treatment & Use of Conventional Medications
30:30 Clinical Ratings: Mood
31:23 Clinical Ratings: Anxiety
31:48 Sleep Disturbance
33:35 Executive Function Results
35:29 Verbal Learning & Memory Results
35:47 Multi-Source Interference Task (MSIT)
37:25 MSIT: Performance
41:12 Observational, Longitudinal Study: Data Summary
43:56 Additional MIND Studies
45:01 Clinical Trial – CBD for Anxiety
45:48 Open-Label Phase: Study Timeline
46:37 Patient Demographics & Baseline Anxiety Ratings
46:50 Clinical Trial – Open Label Results
48:39 Measures of Cognition: Executive Funct
49:10 THC Positive Status
50:30 CBD OPEN LABEL TRIAL CONCLUSIONS
52:20 CONCLUSIONS & FUTURE DIRECTION
53:42 STAFF
_____________________________________________________
• Cannabis and cognition
• Medical cannabis benefits
• Recreational vs medical cannabis
• Cannabis brain imaging
• Cannabis research 2023
• Cannabis for anxiety and sleep
• Long-term cannabis effects
• Cannabis and mental health
• Dr. Stacy Gruber cannabis
• Cannabis neuroimaging studies
• Cannabis for older adults
• Cannabis and cognitive performance
• Cannabis and brain development
• Cannabis for chronic pain
• Cannabis and opioid reduction
_____________________________________________________
